Literature DB >> 19277863

Reduction of brain infarction induced by a transient brain ischemia in mdr1a knockout mice.

Michihiro Murozono1, Shohei Matsumoto, Shinya Okada, Daisuke Nagaoka, Atsushi Isshiki, Yasuo Watanabe.   

Abstract

In order to evaluate the functional role of P-glycoprotein (P-gp) in cerebral ischemia, both multidrug resistance 1a knockout (KO) mice and wild-type mice were subjected to transient focal ischemia under a constant body and brain temperature about 37 degrees C. The results showed that the volume of brain infarction induced by middle cerebral artery occlusion in KO mice was significantly smaller than that seen in wild-type mice, although there were no significant differences in cerebral blood flow, physiological data and on anatomical analysis of cerebrovasculature between both groups. We suggest that multidrug resistance 1a P-gp plays a role for adjusting the expressions of endogenous neuronal cell modulating substances, such as cytokines, neuronal peptides, and others, in the brain, which is consistent with a previous paper (Bobrov et al. Neurosci Lett 24: 6-11, 2008).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19277863     DOI: 10.1007/s11064-009-9943-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  31 in total

1.  Neuroprotective and neurotoxic effects of cyclosporine A on transient focal ischemia in mdr1a knockout mice.

Authors:  Michihiro Murozono; Shohei Matsumoto; Eriko Matsumoto; Atsushi Isshiki; Yasuo Watanabe
Journal:  Eur J Pharmacol       Date:  2004-09-13       Impact factor: 4.432

2.  Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis.

Authors:  T Sakai; K J Johnson; M Murozono; K Sakai; M A Magnuson; T Wieloch; T Cronberg; A Isshiki; H P Erickson; R Fässler
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

3.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

Authors:  F Thiebaut; T Tsuruo; H Hamada; M M Gottesman; I Pastan; M C Willingham
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

4.  Differential overexpression of three mdr gene family members in multidrug-resistant J774.2 mouse cells. Evidence that distinct P-glycoprotein precursors are encoded by unique mdr genes.

Authors:  S I Hsu; L Lothstein; S B Horwitz
Journal:  J Biol Chem       Date:  1989-07-15       Impact factor: 5.157

Review 5.  Biochemistry of multidrug resistance mediated by the multidrug transporter.

Authors:  M M Gottesman; I Pastan
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

6.  Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes.

Authors:  G Raghu; S W Park; I B Roninson; E B Mechetner
Journal:  Exp Hematol       Date:  1996-08       Impact factor: 3.084

7.  P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.

Authors:  A H Schinkel; E Wagenaar; C A Mol; L van Deemter
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

8.  The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis.

Authors:  M J Smyth; E Krasovskis; V R Sutton; R W Johnstone
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

9.  Repetitive/temporal hypoxia increased P-glycoprotein expression in cultured rat brain microvascular endothelial cells in vitro.

Authors:  Liu Xiao-Dong; Yang Zhi-Hong; Yang Hui-Wen
Journal:  Neurosci Lett       Date:  2008-01-31       Impact factor: 3.046

10.  MDR1 gene expression in brain of patients with medically intractable epilepsy.

Authors:  D M Tishler; K I Weinberg; D R Hinton; N Barbaro; G M Annett; C Raffel
Journal:  Epilepsia       Date:  1995-01       Impact factor: 5.864

View more
  5 in total

1.  Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy.

Authors:  Anika M S Hartz; Björn Bauer; Emma L B Soldner; Andrea Wolf; Sandra Boy; Roland Backhaus; Ivan Mihaljevic; Ulrich Bogdahn; Hans H Klünemann; Gerhard Schuierer; Felix Schlachetzki
Journal:  Stroke       Date:  2011-11-23       Impact factor: 7.914

Review 2.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  Spatiotemporal Changes in P-glycoprotein Levels in Brain and Peripheral Tissues Following Ischemic Stroke in Rats.

Authors:  Kelly M DeMars; Changjun Yang; Kimberly E Hawkins; Austin O McCrea; David M Siwarski; Eduardo Candelario-Jalil
Journal:  J Exp Neurosci       Date:  2017-04-07

4.  Neural Progenitor Cell-Derived Extracellular Vesicles Enhance Blood-Brain Barrier Integrity by NF-κB (Nuclear Factor-κB)-Dependent Regulation of ABCB1 (ATP-Binding Cassette Transporter B1) in Stroke Mice.

Authors:  Lin Zhang; Irina Graf; Yaoyun Kuang; Xuan Zheng; Matteo Haupt; Arshad Majid; Ertugrul Kilic; Dirk M Hermann; Marios-Nikos Psychogios; Martin S Weber; Jasmin Ochs; Mathias Bähr; Thorsten R Doeppner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-17       Impact factor: 8.311

5.  P-Glycoprotein Aggravates Blood Brain Barrier Dysfunction in Experimental Ischemic Stroke by Inhibiting Endothelial Autophagy.

Authors:  Liangliang Huang; Yan Chen; Rui Liu; Binbin Li; Xuan Fei; Xiang Li; Ge Liu; Yunman Li; Baohui Xu; Weirong Fang
Journal:  Aging Dis       Date:  2022-10-01       Impact factor: 9.968

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.